What changes in the balm of baldness pills?
The Merck Pharmaceutical Laboratory will expand the package inserts for male pattern baldness and prostate problems to include the sexual side effects. The changes affect the Propecia and Proscar remedies, after the results of clinical trials showed side effects that were not included at the time of approval, the US Food and Drug Administration (FDA) said.
The new topical remedy finasteride, a drug to treat male pattern baldness, will include “libido disorders, ejaculation disorders and orgasm disorders,” the FDA said. In addition, the two marks are being revised to “include a description of reports of male infertility and / or semen reduction, which has normalized or improved after quitting.”
The FDA noted that although clear linkages between finasteride and adverse sexual effects have not been established, the cases suggest a “wider range of adverse effects than previously reported in patients taking the drugs.” Clinical trials showed that 3.8% of men who took the finasteride drug reported one or more side effects, versus 2.1% of those taking a placebo. “Propecia is generally well tolerated and effective for their respective uses according to the approved product insert,” said Merck, one of the finasteride-based laboratories.
Source: edited text from Uol news. From AFP in Washington